Michael Exton

Chief Executive Officer, Lexicon Pharmaceuticals.

Companies

Lexicon PharmaceuticalsBoard member Jul 8, 2024 to now¹
Lexicon PharmaceuticalsChief executive officer Jul 8, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lexicon Pharmaceuticals LXRX298,432 shares²$492.4K at $1.65Feb 28, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 28, 2026Shares withheld for tax 204,831 shares at $1.47 of Lexicon Pharmaceuticals²
Feb 28, 2026Exercised options 503,263 shares of Lexicon Pharmaceuticals²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLexicon Pharmaceuticals, Board member
2
SEC EDGARLexicon Pharmaceuticals shares after the filing of Feb 28, 2026